Stockreport

Cellyan Biotechnology receives Nasdaq bid price deficiency notice [Seeking Alpha]

Cellyan Biotechnology Co., Ltd - Class A Ordinary Shares  (HKPD) 
PDF The deficiency arose after the company's shares traded below $1 for 30 consecutive business days from November 26, 2025 to January 9, 2026. Cellyan has been granted a [Read more]